from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0001/dnaA

LFCtreatmentdescriptionclass of inhibitor

-0.147

Amikacinug/mL Amikacintranslation

0.115

Cap5-10ug/mL Capreomycintranslation

-0.390

Rox10-50 ug/mL Roxithromycintranslation

0.057

SM2-5 ug/mL Streptomycintranslation

-1.928

Tet5-10 ug/mL Tetracyclinetranslation

-0.528

Rif0.2-5ug/mL Rifampicintranscription

-0.017

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.473

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.214

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.258

CPZ10-50 ug/mL Chlorpromazinerespiration

0.755

Clofazimine10-13 ug/mL Clofaziminerespiration

0.643

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.445

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.274

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.181

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.683

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.729

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.234

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.519

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.107

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.702

KCN5-20 ug/mL Potassium cyaniderespiration

-0.296

NaN30.2-2 mM Sodium aziderespiration

1.097

Nigericin50 uM Nigericinrespiration

-1.367

TRC10-150 ug/mL Triclosanrespiration

-1.220

TRZ10-25 ug/mL Thioridazinerespiration

-0.403

Valinomycin0.5-10 uM Valinomycinrespiration

1.585

ZnSO42 mM ZnSO4respiration

-0.309

menadione6-10 ug/mL Menadionerespiration

0.816

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.752

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.092

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.151

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.253

NRP_1Non-replicating persistence stage 1dosRassociated

0.549

Amp0.2mg/mL AmpicillincellWall

0.037

Cephalexin20-100 ug/mL CephalexincellWall

0.388

Cerulenin0.32-5 ug/mL CerulenincellWall

0.536

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.233

EMB10-20 ug/mL EthambutolcellWall

-0.431

Eta12-40 ug/mL EthionamidecellWall

-0.601

INH0.2-0.4 ug/mL IsoniazidcellWall

0.068

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.371

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.558

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.087

BZA0.12 mg/mL BenzamidearomaticAmides

-0.025

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.062

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.091

H2O24 mM hydrogen peroxideDNAdamaging

0.182

Levo10 ug/mL LevofloxacinDNAdamaging

0.145

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.359

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.223

UVUV-irradiationDNAdamaging

-0.581

ARP41-4 ug/mL Antitubercular compound ARP4?

1.001

Antimycin12.5-50 ug/mL Antimycin A?

0.683

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.338

PA_110-50 ug/mL Antitubercular compound PA-1?

0.343

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.730

PA8240.2-2 ug/mL PA-824?

-1.767

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.349

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.910

Verapamil50 uM Verapamil?

0.353

mercaptoethanol2 mM 2-Mercaptoethanol?

1.126

methoxatin10-20 ug/mL Methoxatin?